SpaceX Puts the Wheels in Motion for Its IPO: 5 Reasons Why I Plan to Completely Avoid It

SpaceX has confidentially filed for a U.S. IPO reportedly targeting a ~$1.75 trillion valuation and a $50–75 billion raise. The company generated roughly $15–16B in revenue and about $8B in profit last year, implying a triple‑digit P/E and >60x trailing sales if the $1T+ valuation ascribed to SpaceX proper is accurate. The author plans to avoid the IPO citing five risks: an unjustified valuation, Elon Musk's history of overpromising, diluted CEO attention across multiple trillion‑dollar companies, capital‑intensive execution and dilution risk, and elevated market-wide valuations (high Shiller P/E) that heighten downside risk.

Analysis

The headline IPO will act less like a single security event and more like a capital-supply shock: large, concentrated primary issuance from a high-profile founder will temporarily siphon institutional demand away from other long-duration growth names and compress liquidity in the largest growth desks for weeks. That reallocative pressure is the faster, higher-probability mechanism to move markets (days→months) versus the slower realization of SpaceX operating risks (12–36 months).

Second-order winners are defensively positioned hardware and cash-generative names that can absorb rebalanced allocations (large-cap, high-FCF tech and legacy chip suppliers), while the obvious losers are high-beta, founder-dependent equities and small cap satellite plays exposed to execution risk. A failed early Starship test, unanticipated dilution or regulatory scrutiny would crystallize those flows and amplify outflows into perceived “safer” AI exposure (NVIDIA) and consumer staples.

Key catalysts and time horizons to watch: IPO pricing and tranche size (days), post-debut retail/institutional placement dynamics and immediate lock-up terms (0–3 months), followed by execution-readouts from Starship/Starlink and xAI monetization milestones (6–24 months) that determine whether dilution or earnings ramp becomes the dominant narrative. Tail risks — catastrophic launch failure, a major regulatory action against Musk-owned platforms, or a broader multiple compression event tied to the Shiller re-rate — would flip the trade rapidly.

Practically, this is an event to harvest volatility rather than buy headline exposure. We should tactically reduce conviction in founder-centric longs, short execution-levered small-caps, and redeploy into liquid AI and large-cap defensive tech while using option structures to cap downside and benefit from asymmetric dispersion between winners and losers.

Key Decisions for Investors

• Initiate a 6–12 month long NVDA call spread (buy calls / sell higher strike calls) sized 1.5% NAV. Rationale: capture a market re-allocation into durable AI leaders if IPO hype fades; target asymmetric 2.5x payoff vs capped premium loss. Exit/roll at 40–60% realized gain or if NVDA underperforms broad market by >10% in 30 days.
• Establish a tactical 3–6 month bearish position on TSLA: buy 1–1 put spread 20–30% OTM (size 1% NAV) paired with a 1% NAV long NVDA (or AAPL) hedge. Rationale: hedge founder-distraction and potential outflow from Tesla into SpaceX; expected payoff if TSLA re-rates down 20–30% post-IPO. Max loss = premium paid; cut loss if TSLA closes >15% above entry for 5 trading days.
• Short ASTS outright (size 0.5–1% NAV) with a tight stop at +20%. Rationale: small satellite OEMs are execution- and schedule-sensitive; IPO-induced sentiment rotation increases downside risk. Target 40–60% downside within 3–12 months on missed launches or partner delays; stop to limit headline-driven squeezes.
• Reallocate 2–3% NAV from high-P/E growth names into AAPL or INTC stock (buy-and-hold 12 months). Rationale: defensive liquidity soak-up during IPO window and potential sector rotation into cash-flowing hardware. Expect 8–15% upside or dividend carry over 12 months; reassess at 6 months against lock-up expiries and capex transparency from the IPO.